Centro Universitario de Ciencias de la Salud, Departamento de Biología Molecular y Genómica, Instituto de Biología Molecular en Medicina, Universidad de Guadalajara, Guadalajara 44340, Jalisco, México.
Escuela de Medicina y Ciencias de la Salud, Tecnológico de Monterrey, Campus Guadalajara, Zapopan 45201, Jalisco, México.
Viruses. 2021 Jun 18;13(6):1167. doi: 10.3390/v13061167.
The immunopathogenesis and molecular mechanisms involved during a hepatitis B virus (HBV) infection have made the approaches for research complex, especially concerning the patients' responses in the course of the early acute stage. The study of molecular bases involved in the viral clearance or persistence of the infection is complicated due to the difficulty to detect patients at the most adequate points of the disease, especially in the time lapse between the onset of the infection and the viral emergence. Despite this, there is valuable data obtained from animal and in vitro models, which have helped to clarify some aspects of the early immune response against HBV infection. The diversity of the HBV (genotypes and variants) has been proven to be associated not only with the development and outcome of the disease but also with the response to treatments. That is why factors involved in the virus evolution need to be considered while studying hepatitis B infection. This review brings together some of the published data to try to explain the immunological and molecular mechanisms involved in the different stages of the infection, clinical outcomes, viral persistence, and the impact of the variants of HBV in these processes.
乙型肝炎病毒(HBV)感染涉及的免疫发病机制和分子机制使得研究变得复杂,尤其是在急性早期阶段,患者的反应更复杂。由于难以在疾病的最佳时间点检测到患者,尤其是在感染开始和病毒出现之间的时间间隔内,因此研究与病毒清除或感染持续存在相关的分子基础非常复杂。尽管如此,从动物和体外模型中获得了有价值的数据,这些数据有助于阐明针对 HBV 感染的早期免疫反应的一些方面。HBV(基因型和变体)的多样性已被证明不仅与疾病的发展和结果有关,而且与治疗反应有关。这就是为什么在研究乙型肝炎感染时需要考虑病毒进化涉及的因素。这篇综述汇集了一些已发表的数据,试图解释感染不同阶段、临床结局、病毒持续存在以及 HBV 变体在这些过程中的作用所涉及的免疫和分子机制。